0001209191-20-056365.txt : 20201030 0001209191-20-056365.hdr.sgml : 20201030 20201030203009 ACCESSION NUMBER: 0001209191-20-056365 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20201028 FILED AS OF DATE: 20201030 DATE AS OF CHANGE: 20201030 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: FEES JESSICA CENTRAL INDEX KEY: 0001760391 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-38459 FILM NUMBER: 201278733 MAIL ADDRESS: STREET 1: C/O SURFACE ONCOLOGY, ICN. STREET 2: 50 HAMPSHIRE STREET 8TH FLOOR CITY: CAMBRIDGE STATE: MA ZIP: 02139 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Surface Oncology, Inc. CENTRAL INDEX KEY: 0001718108 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 50 HAMPSHIRE STREET, 8TH FLOOR CITY: CAMBRIDGE STATE: MA ZIP: 02139 BUSINESS PHONE: 617-714-4096 MAIL ADDRESS: STREET 1: 50 HAMPSHIRE STREET, 8TH FLOOR CITY: CAMBRIDGE STATE: MA ZIP: 02139 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2020-10-28 0 0001718108 Surface Oncology, Inc. SURF 0001760391 FEES JESSICA C/O SURFACE ONCOLOGY, INC. 50 HAMPSHIRE STREET, 8TH FLOOR CAMBRIDGE MA 02139 0 1 0 0 See Remarks Common Stock 2020-10-28 4 M 0 4773 4.136 A 100678 D Common Stock 2020-10-28 4 M 0 122 4.27 A 100800 D Stock Option (Right to Buy) 4.136 2020-10-28 4 M 0 4773 0.00 D 2026-12-09 Common Stock 4773 682 D Stock Option (Right to Buy) 4.27 2020-10-28 4 M 0 122 0.00 D 2029-03-01 Common Stock 122 14078 D This option shall vest in 48 equal monthly installments after January 1, 2017. The stock option vests and becomes exercisable in 48 equal monthly installments after November 18, 2018. Title: Principal Accounting Officer, Principal Financial Officer /s/ Jessica Fees 2020-10-30